This investigation addressed the hypothesis that topical 5αTHB can effectively reduce skin inflammation through a GR-dependent mechanism, but with limited effects on processes such as angiogenesis and collagen deposition, the inhibition of which underpin most common problems associated with topical glucocorticoid therapy. Here, NR3C1 is linked to dermatitis.